Percheron Therapeutics Ltd (ATHJF)
0.025
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Percheron Therapeutics Enterprise Value: 10.84M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 10.84M |
May 16, 2024 | 10.84M |
May 15, 2024 | -2.687M |
May 14, 2024 | -2.687M |
May 13, 2024 | -2.687M |
May 10, 2024 | -2.687M |
May 09, 2024 | -2.687M |
May 08, 2024 | -2.687M |
May 07, 2024 | -2.687M |
May 06, 2024 | -2.687M |
May 03, 2024 | -2.687M |
May 02, 2024 | -2.687M |
May 01, 2024 | -2.687M |
April 30, 2024 | -2.687M |
April 29, 2024 | -2.687M |
April 26, 2024 | -2.687M |
April 25, 2024 | -2.687M |
April 24, 2024 | -2.687M |
April 23, 2024 | -2.687M |
April 22, 2024 | -2.687M |
April 19, 2024 | -2.687M |
April 18, 2024 | -2.687M |
April 17, 2024 | -2.687M |
April 16, 2024 | -2.687M |
April 15, 2024 | -2.687M |
Date | Value |
---|---|
April 12, 2024 | -2.687M |
April 11, 2024 | -2.687M |
April 10, 2024 | -2.687M |
April 09, 2024 | -2.687M |
April 08, 2024 | -2.687M |
April 05, 2024 | -2.687M |
April 04, 2024 | -2.687M |
April 03, 2024 | -2.687M |
April 02, 2024 | -2.687M |
April 01, 2024 | -2.687M |
March 28, 2024 | -2.687M |
March 27, 2024 | -2.687M |
March 26, 2024 | -2.687M |
March 25, 2024 | -2.687M |
March 22, 2024 | -2.687M |
March 21, 2024 | -2.687M |
March 20, 2024 | -2.687M |
March 19, 2024 | -2.687M |
March 18, 2024 | -2.687M |
March 15, 2024 | -2.687M |
March 14, 2024 | -2.687M |
March 13, 2024 | -2.687M |
March 12, 2024 | -2.687M |
March 11, 2024 | -2.687M |
March 08, 2024 | -2.687M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.687M
Minimum
Jan 02 2024
166.27M
Maximum
Oct 29 2021
38.73M
Average
30.00M
Median
Enterprise Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 5.257M |
Immutep Ltd | -- |
Opthea Ltd | 125.45M |
Mesoblast Ltd | -- |
Enterprise Value Related Metrics
Earnings Yield | -41.50% |